Retatrutide safety: the law, the raids and the vials

Everything in this section is about the gap between the drug tested in Lilly's trials and the products sold online under its name. It is written for three people: someone weighing up whether to use one, someone who already has, and someone worried about a friend or family member who has.

Two different things with one name

The trial results on this site come from a pharmaceutical-grade product made by Lilly, given to screened adults under medical supervision, with regular blood tests and clinical monitoring. Nothing else is retatrutide in that sense.

The products sold on social media and websites as "reta" are made by someone else. Nobody outside the seller knows who, where, or from what. The MHRA's view is that any product sold in the UK claiming to contain retatrutide is likely to be illegal and potentially dangerous.^[7]

The law

Retatrutide is not listed under the Misuse of Drugs Act 1971, so having it is not a criminal offence.^[2] It is, however, a medicine with no marketing authorisation. Under the Human Medicines Regulations 2012 an unlicensed medicine cannot be sold, supplied or advertised for people to use, whatever its label says.^[3] The legal explainer goes through what that means for a person, a seller and a clinic.

Enforcement

Between October 2025 and May 2026 the MHRA's Criminal Enforcement Unit raided a warehouse outside Northampton, a farm and a house in Lincolnshire, and a country estate near Northampton.^[7][8][4] At the first site officers found more than 2,000 filled retatrutide and tirzepatide pens, tens of thousands of empty pens ready to be filled, and raw chemical ingredients. Empty pens plus raw powder is what a hand-filling operation looks like. The enforcement page has the full timeline.

What testing has found

Independent laboratories have tested products sold as retatrutide and semaglutide. They found a vial with nearly double the labelled amount, a vial with none of the peptide at all, purity as low as 16.6%, and bacterial endotoxin in every semaglutide vial in one study.^[9][5][10] In the UK, fake weight-loss pens have been found to contain insulin.^[11] What is actually in the vials explains each failure and what it does to a person. Why a certificate of analysis does not make it safe covers the paperwork sellers offer in response.

The 2026 liver-injury cluster

In June 2026 Victoria's Chief Health Officer issued an alert after six people developed acute liver injury following use of products labelled Retatrutide, Reta, R-10 or R-20. Further cases have been reported since. Doctors believe an additional contaminant, rather than retatrutide itself, may be responsible.^[6] One woman spent a month in hospital after two injections and came close to needing a transplant.^[12] The cluster page lists the symptoms to watch for.

If you have already used a product

You are not in trouble. Possession is not an offence, and telling a doctor or nurse what you used will not get you reported. What matters is:

• knowing the warning signs of liver injury and infection and acting on them the same day;
• telling your GP, so a blood test can check your liver, kidneys and pancreas;
• reporting any reaction to the MHRA Yellow Card scheme, which accepts reports about unlicensed and fake products and uses them to spot clusters like the one in Victoria.^[13]

In this section

1. 1.Is retatrutide legal in the UK? The law in plain English

   Retatrutide is not a controlled drug, but selling or supplying it for human use is an offence. What 'research use only', unlicensed and import mean.

2. 2.MHRA enforcement: three retatrutide raids in seven months

   The MHRA raids on illegal weight-loss injection factories in Northampton and Lincolnshire, what was seized, Lilly's lawsuits, and what empty pens tell you.

3. 3.What is actually in the vials sold as retatrutide?

   Independent lab tests of products sold as retatrutide found double strength, no peptide at all, 16.6% purity and endotoxin. What each failure means.

4. 4.The 2026 liver-injury cluster linked to 'retatrutide'

   At least six people in Victoria, Australia developed acute liver injury after using products labelled retatrutide. What happened and what to watch for.

5. 5.Why a certificate of analysis does not make a vial safe

   A COA reports one lab test on one sample. It cannot prove identity, strength, sterility or endotoxin in your vial, and it is not GMP.

6. 6.Counterfeit retatrutide pens: why there is no real one

   Lilly has never sold retatrutide in a pen. Every 'retatrutide pen' is hand-filled by someone else, and UK fake pens have contained insulin.

7. 7.Injecting unlicensed peptides: infection and sepsis risks

   Why an unlicensed injectable is nothing like a supplement: sterility, endotoxin, abscesses, cellulitis, sepsis, blood-borne viruses, and where to get help.

8. 8.Yellow Card: reporting a reaction to an unlicensed product

   How to report a side effect or fake product to the MHRA Yellow Card scheme, why it matters even for unlicensed retatrutide, and how to report a seller.

9. 9.Talking to your GP about retatrutide use

   What to say to your GP if you have used a product sold as retatrutide, why honesty matters, the blood tests they may order, and confidentiality.